Literature DB >> 18180897

Study on graded therapy of hemophilic arthritis by integrative traditional Chinese and Western medicine.

Shan-Xi Liu1, Lin Jiang, Xin Liang, Wei-wei Kong, Jing Chen, Yi-guo Liu, Le-qin He.   

Abstract

OBJECTIVE: To study the effect and safety of graded therapy featuring integrative traditional Chinese and Western medicine for the treatment of hemophilic arthritis.
METHODS: Forty patients with hemophilic arthritis were hospitalized randomly, with their blood coagulation factor activity determined by one-stage method and their arthritis classified into 4 stages. The treatment was applied according to the stage of arthritis and finding of intra-articular cavity puncture. For stage I, based on the principle of RICE (rest, ice, compression and elevation), 1.8 g of Xuefuda was medicated orally once per day, intravenous dripping of 250 mL of hemostasis mixture twice a day and 1.2 g of clindamycin per day were also given for hemostasis and anti-inflammation. For stage II-III, Kangyanling was additionally administered via intra-articular cavity injection twice a week, 2 mL every time, for 5-6 times in total. For stage IV, the drug for intra-articular cavity injection was replaced with 25 mg of sodium hyaluronate and the frequency of injection reduced to every two weeks, for 5-6 times in total. Coagulation factors III and IV as well as blood plasma were not given in the whole treatment course. Short-term therapeutic effects and adverse reaction in patients were evaluated, and the long-term effects were followed-up after patients left the hospital with 6-month consolidation therapy by Xuefuda.
RESULTS: After a 3-week treatment, 33 patients (82.5%) were completely remitted; 5 (12.5%) were partially remitted and 2 (5.0%) un-remitted, setting the short-term effective rate at 95.0% (38 cases). The 6-month follow-up showed that except for a relapse in 2 and 4 patients of stage III and IV respectively, long-term remission displayed in all the other 34 patients, with the remission sustaining rate being 85.0%. No complication such as an infection, bleeding or aggravating pain occurred in the 215 times intra-articular puncturing conducted in the 40 patients. Normal figures were shown in liver and kidney function, electrolytes, ECG, blood glucose and routine test of blood and urine throughout the course.
CONCLUSION: The graded treatment of integrative medicine for hemophilia with non-blood preparation has a favorable effect and is safe or without any adverse reaction, which opens a high efficacy and new safe path and thinking for the treatment of and deformity prevention in the hemophilic patients.

Entities:  

Mesh:

Year:  2007        PMID: 18180897     DOI: 10.1007/s11655-007-0301-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  10 in total

1.  Programmed healing of membranous bone in the fetal lamb.

Authors:  Hrayr Shahinian; Jamie P Levine; James P Bradley; Catherine O'Hara; Susan A McCormick; Yoonah Kim; Michael T Longaker
Journal:  Ann Plast Surg       Date:  2005-01       Impact factor: 1.539

2.  Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis.

Authors:  R Theiler; P Brühlmann
Journal:  Curr Med Res Opin       Date:  2005-11       Impact factor: 2.580

3.  Nonunion of the diaphysis of long bones.

Authors:  Sudhir Babhulkar; Ketan Pande; Sushrut Babhulkar
Journal:  Clin Orthop Relat Res       Date:  2005-02       Impact factor: 4.176

4.  Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience.

Authors:  Robert J Petrella
Journal:  Am J Phys Med Rehabil       Date:  2005-04       Impact factor: 2.159

5.  Pulmonary embolization of vascular occlusion coils in dogs with patent ductus arteriosus.

Authors:  Ashley B Saunders; Matthew W Miller; Sonya G Gordon; Anne Bahr
Journal:  J Vet Intern Med       Date:  2004 Sep-Oct       Impact factor: 3.333

6.  A radiologic classification of hemophilic arthropathy.

Authors:  H Pettersson; A Ahlberg; I M Nilsson
Journal:  Clin Orthop Relat Res       Date:  1980-06       Impact factor: 4.176

7.  In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody.

Authors:  Jean Guy G Gilles; Sabrina C Grailly; Marc De Maeyer; Marc G Jacquemin; Luc P VanderElst; Jean-Marie R Saint-Remy
Journal:  Blood       Date:  2003-12-11       Impact factor: 22.113

8.  Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.

Authors:  Valder R Arruda; Joerg Schuettrumpf; Roland W Herzog; Timothy C Nichols; Nancy Robinson; Yasmin Lotfi; Federico Mingozzi; Weidong Xiao; Linda B Couto; Katherine A High
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

Review 9.  Maintenance of musculoskeletal function in people with haemophilia.

Authors:  L R Battistella
Journal:  Haemophilia       Date:  1998       Impact factor: 4.287

10.  Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice.

Authors:  Antonia Follenzi; Manuela Battaglia; Angelo Lombardo; Andrea Annoni; Maria Grazia Roncarolo; Luigi Naldini
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.